You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 7 Current »

eHN Guideline

Data  Description Preferred Code Systems Arbetsgruppens ("Svensk") tolkning av informationselementetUtvärderingsparametrar


* ** A.2 Patient summary body data elements Ur uppdraget:
• Socialstyrelsens arbete med förvaltningen och vidareutvecklingenav informationsspecifikationen för den nationellaUppmärksamhetsinformation (UMI)
•systemleverantörernas stöd för Socialstyrelsensinformationsspecifikation, där bl.a. Cambio redan implementeratstöd
•pågående diskussioner hos Socialstyrelsen om att lägga tillvarningar för specifika tillstånd, som pacemakerimplantat ochblodprover, vilket är en del av Socialstyrelsensuppmärksamhetsinformation för att minimera risker.






A.2.1  Alerts






A.2.1.1  Allergy






A.2.1.1.1 Allergy description Textual description of the allergy or intolerance 

Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.3 Type of propensity This element describes whether this condition refers to an allergy, non-allergy intolerance, or unknown class of intolerance (not known to be allergy or intolerance) SNOMED CT GPS 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.3 Allergy manifestation Description of the clinical manifestation of the allergic reaction. Example: anaphylactic shock, angioedema (the clinical manifestation also gives nformation about the severity of the observed reaction) SNOMED CT GPS
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.4 Severity Severity of the clinical manifestation of the allergic reaction.  SNOMED CT GPS
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.5 Criticality Potential risk for future life-threatening adverse reactions when exposed to a substance known to cause an adverse reaction. SNOMED CT GPS 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.6 Onset date Date of the observation of the reaction ISO 8601 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.7 End Date Date of resolution of the allergy (e.g. when the clinician deemed there is no longer any need to track the underlying condition) ISO 8601 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.8 Status Current status of the allergy or intolerance, for example, whether it is active, in remission, resolved, etc. SNOMED CT GPS 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.9 Certainty Assertion about the certainty associated with a propensity, or potential risk, of a reaction to the identified substance. Diagnostic and/or clinical evidence of condition. SNOMED CT GPS 
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.1.10 Agent or Allergen A specific allergen or other agent/substance (drug, food, chemical agent, etc.) to which the patient has an adverse reaction propensity. SNOMED CT GPS (for non-drug allergy) or ATC* (for drug allergy) (IDMP, when available)
Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen


A.2.1.2 Medical alert information (other alerts not included in allergies)






A.2.1.2.1 Healthcare alert description Description of medical alerts in textual format: any clinical information that is imperative to know so that the life or health of the patient does not come under threat. -
Example 1: intolerance to aspirin due to gastrointestinal bleeding.
Example 2: intolerance to captopril because of cough (the patient is not allergic but can't tolerate it because of persistent cough)
Example 3: the patient has a rare disease that requires special treatment 
Example 4: Airway Alert / Difficult Intubation
Example 5: Diagnoses such as malignant hyperthermia, porphyria, and bleeding disorders; special treatments like anticoagulants or immunosuppressants;  implanted devices.
Example 6: transplanted organs illustrate other information that has to be taken into account in a healthcare contact. 
Example 7: participation in a clinical trial that has to be taken into account in a healthcare contact.


Beskrivning av hur lösningen möter EDHS krav


Bedömning


Täckningsgrad


Kvalité på informationen



Xt-EHR Logical model


ShortDefinitionMinMaxType(s)

Binding Strength


Binding Description



B.1.1 - AlertsAlert section includes information about allergies, intolerances and other substantial alerts or warnings that health professionals should be aware of.11Base





B.1.1.1 - Section narativeNarative content of the section. This narative shell containing either narative description of both allergy and alerts, or similar narative sub-section elements shell be provided.01string





B.1.1.2 - AllergyA record of allergies and intolerances.1*https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSAllergyIntolerance





B.1.1.3 - Medical alertMedical alert information (other alerts not included in allergies).0*https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSAlertFlag






ShortDefinitionMinMaxType(s)Binding StrengthBinding Description



Allergy intolerance modelC.21 - EHDS refined base model for Allergy Intolerance0*






C.21.1 - IdentifierAppointment identifier0*Identifier





C.21.2 - Allergy descriptionTextual description of the allergy or intolerance01string





C.21.3 - Type of propensityThis element describes whether this condition refers to an allergy, non-allergy intolerance, or unknown class of intolerance (not known to be allergy or intolerance)01CodeableConceptpreferredSNOMED CT



C.21.4 - Allergy manifestationDescription of the clinical manifestation of the allergic reaction including date of manifestation and severity. Example: anaphylactic shock, angioedema (the clinical manifestation also gives information about the severity of the observed reaction). Multiple manifestations could be provided.0*Base





C.21.4.1 - DateDate and time of allergy manifestation01dateTime





C.21.4.2 - Severity Severity of the clinical manifestation of the allergic reaction.01CodeableConceptpreferredSNOMED CT



C.21.4.3 - DescriptionDescription of the event as a whole01string





C.21.4.4 - ManifestationClinical symptoms/signs associated with the Event0*CodeableConceptpreferredSNOMED CT



C.21.5 - CriticalityPotential risk for future life-threatening adverse reactions when exposed to a substance known to cause an adverse reaction.01CodeableConceptpreferredSNOMED CT



C.21.6 - Onset dateDate of onset of allergy, e.g., date of the first observation of the reaction. Partial date could be used. or life period (childhood, adolescence).01dateTime





C.21.7 - Onset life periodDate of onset of allergy, e.g., date of the first observation of the reaction expressed usingor life period (childhood, adolescence, etc.).01CodeableConceptpreferredSNOMED CT



C.21.8 - End dateDate of resolution of the allergy (e.g. when the clinician deemed there is no longer any need to track the underlying condition)01dateTime





C.21.9 - End date life periodDate of resolution of the allergy (e.g. when the clinician deemed there is no longer any need to track the underlying condition) exprssed using life period (childhood, … )01CodeableConceptpreferredSNOMED CT



C.21.10 - StatusCurrent status of the allergy or intolerance, for example, whether it is active, in remission, resolved, and so on …01CodeableConceptpreferredSNOMED CT



C.21.11 - CertaintyAssertion about the certainty associated with a propensity, or potential risk, of a reaction to the identified substance. Diagnostic and/or clinical evidence of condition.01CodeableConceptpreferredSNOMED CT



C.21.12 - Agent or AllergenA specific allergen or other agent/substance (drug, food, chemical agent, etc.) to which the patient has an adverse reaction propensity.11CodeableConceptpreferredSNOMED CT, ATC, (IDMP / EMA SPOR SMS)



C.21.13 - SubjectThe patient who has the allergy or intolerance.11Reference(https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSPatient)






ShortDefinitionMinMaxType(s)Binding StrengthBinding Description



Alert flag modelC.22 - EHDS refined base model for Alert flag0*






C.22.1 - IdentifierFlag identifier (Business identifiers assigned to this flag).0*Identifier





C.22.2 - TextA human-readable narrative that contains a summary of the flag and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it \"clinically safe\" for a human to just read the narrative.
Example 1: intolerance to aspirin due to gastrointestinal bleeding.
Example 2: intolerance to captopril because of cough (the patient is not allergic but can't tolerate it because of persistent cough)
Example 3: the patient has a rare disease that requires special treatment
Example 4: Airway Alert / Difficult Intubation
Example 5: Diagnoses such as malignant hyperthermia, porphyria, and bleeding disorders; special treatments like anticoagulants or immunosuppressants; implanted devices.
Example 6: transplanted organs illustrate other information that has to be taken into account in a healthcare contact.
Example 7: participation in a clinical trial that has to be taken into account in a healthcare contact.
01Narrative





C.22.3 - PriorityA code that identifies the priority of the alert.0*CodeableConceptpreferredhl7:Flag-priority-code



C.22.4 - StatusCurrent status of the flag, Indicates whether this flag is active and needs to be displayed to a user, or whether it is no longer needed or was entered in error.01CodeableConceptpreferredhl7:Flag-status



C.22.5 - CodeA coded or textual representation of the flag.11CodeableConceptpreferredSNOMED CT



C.22.6 - SubjectWho/What this flag is a record of11Reference(Patient)





C.22.7 - PeriodTime period when flag is active. The period of time from the activation of the flag to inactivation of the flag. If the flag is active, the end of the period should be unspecified.01Period





C.22.8 - EncounterThis alert is only relevant during the encounter.01Reference(Encounter)





C.22.9 - AuthorThe person, organization or device that created the flag.01Reference(https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSHealthProfessional|https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSOrganization|https://www.xt-ehr.eu/specifications/fhir/StructureDefinition/EHDSDevice)





  • No labels